106 related articles for article (PubMed ID: 9571978)
1. [Pilot study of cisplatin, ifosfamide and irinotecan (CPT-11) with granulocyte colony-stimulating factor support (CIC-regimen) in relapsed small-cell lung cancer].
Fujita A; Takabatake H; Tagaki S; Sekine K
Gan To Kagaku Ryoho; 1998 Apr; 25(5):761-4. PubMed ID: 9571978
[No Abstract] [Full Text] [Related]
2. Combination of cisplatin, ifosfamide, and irinotecan with rhG-CSF support for the treatment of refractory or relapsed small-cell lung cancer.
Fujita A; Takabatake H; Tagaki S; Sekine K
Oncology; 2000 Aug; 59(2):105-9. PubMed ID: 10971167
[TBL] [Abstract][Full Text] [Related]
3. [Phase I study of cisplatin, ifosfamide and CPT11 with granulocyte colony-stimulating factor support in advanced non-small cell lung cancer].
Fujita A; Takabatake H; Tagaki S; Sekine K
Gan To Kagaku Ryoho; 1996 Sep; 23(10):1285-90. PubMed ID: 8831740
[TBL] [Abstract][Full Text] [Related]
4. [Period of time patients with advanced non-small cell lung cancer could remain at home during CIC--therapy (cisplatin + ifosfamide + CPT-11)].
Fujita A; Igami Y; Takabatake H; Tagaki S; Yamamoto R; Sekine K
Gan To Kagaku Ryoho; 1999 May; 26(6):805-11. PubMed ID: 10410150
[TBL] [Abstract][Full Text] [Related]
5. [Combination of irinotecan hydrochloride and etoposide for treatment of refractory or relapsed small-cell lung cancer].
Negoro S; Masuda N
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1105-8. PubMed ID: 10945003
[TBL] [Abstract][Full Text] [Related]
6. Ifosfamide, cisplatin and etoposide (ICE) combined chemotherapy with recombinant human granulocyte colony-stimulating factor support in small cell lung cancer.
Hastürk S; Kurt B; Kocabas A; Orüç O; Burgut R
J Chemother; 1997 Feb; 9(1):66-71. PubMed ID: 9106021
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancer.
Fennell DA; Steele JP; Shamash J; Slater SE; Sheaff MT; Wells P; Rudd RM; Stebbing J
Int J Cancer; 2007 Dec; 121(11):2575-7. PubMed ID: 17680556
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of systemic chemotherapy in adenocarcinoma of the lung with pleuritis carcinomatosa].
Fujita A; Takabatake H; Tagaki S; Sekine K
Gan To Kagaku Ryoho; 1997 Oct; 24(13):1987-91. PubMed ID: 9350247
[TBL] [Abstract][Full Text] [Related]
9. Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer.
Goto K; Sekine I; Nishiwaki Y; Kakinuma R; Kubota K; Matsumoto T; Ohmatsu H; Niho S; Kodama T; Shinkai T; Tamura T; Ohe Y; Kunitoh H; Yamamoto N; Nokihara H; Yoshida K; Sugiura T; Matsui K; Saijo N
Br J Cancer; 2004 Aug; 91(4):659-65. PubMed ID: 15280919
[TBL] [Abstract][Full Text] [Related]
10. Multicyclic dose-intensive chemotherapy supported by autologous blood progenitor cell transplantation for relapsed small cell lung cancer.
Fujimoto N; Ueoka H; Kiura K; Tabata M; Bessho A; Takata I; Sunami K; Hiramatsu Y; Ikeda K; Tanimoto M; Harada M
Anticancer Res; 2003; 23(5b):4229-32. PubMed ID: 14666630
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer.
Fujita A; Fukuoka S; Takabatake H; Tagaki S; Sekine K
Oncology; 2000 Nov; 59(4):291-5. PubMed ID: 11096340
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer.
Mori K; Machida S; Yoshida T; Yoshida M; Kano Y; Tominaga K
Cancer Chemother Pharmacol; 1999; 43(6):467-70. PubMed ID: 10321506
[TBL] [Abstract][Full Text] [Related]
13. A pilot study with cisplatin, ifosfamide and weekly administration of vinorelbine as an outpatient combination chemotherapy for advanced non small cell lung cancer.
Tibaldi C; Baldini E; Ricci S; Conte PF
Anticancer Res; 1996; 16(5B):3213-5. PubMed ID: 8920792
[TBL] [Abstract][Full Text] [Related]
14. Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy.
Huisman C; Biesma B; Postmus PE; Giaccone G; Schramel FM; Smit EF
Br J Cancer; 2001 Nov; 85(10):1456-61. PubMed ID: 11720428
[TBL] [Abstract][Full Text] [Related]
15. A phase I study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support in the treatment of advanced non-small cell lung cancer.
Mori K; Hirose T; Machida S; Yokoyama K; Tominaga K
Eur J Cancer; 1997 Mar; 33(3):503-5. PubMed ID: 9155540
[TBL] [Abstract][Full Text] [Related]
16. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L
Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
[TBL] [Abstract][Full Text] [Related]
17. A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study.
Frasci G; Nicolella G; Comella P; Carreca I; DeCataldis G; Muci D; Brunetti C; Natale M; Piantedosi F; Russo A; Palmeri S; Comella G; Panza N
Br J Cancer; 2001 May; 84(9):1166-71. PubMed ID: 11336465
[TBL] [Abstract][Full Text] [Related]
18. A phase II study of a three-drug combination (cisplatin, ifosfamide and vinorelbine) plus granulocyte-colony stimulating factor in advanced non small cell lung cancer.
Tognoni A; Cadenotti L; Pensa F; Vaira F; Vigani A; Bancalari L; Cordani S; Maggiani R; Canessa PA; Pronzato P
J Chemother; 1999 Aug; 11(4):306-9. PubMed ID: 10465134
[TBL] [Abstract][Full Text] [Related]
19. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
[TBL] [Abstract][Full Text] [Related]
20. Progress in treatment of small-cell lung cancer: role of CPT-11.
Saijo N
Br J Cancer; 2003 Dec; 89(12):2178-83. PubMed ID: 14676791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
